Results for this period
Full year1 June 2020 to 31 May 2021Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The number of new recurring members for health foods increased substantially as a result of proactive advertising investment, the online Chinese herbal medicine shop business acquired through M&A contributed to higher revenue, and sales support using celebrities and wholesale sales for television shopping grew. Meanwhile, development and operating costs for the SOKUYAKU app, organizational development costs for the media business, and personnel expenses weighed on profit.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 June 2020 to 31 May 2021 |
| Net Sales | 8,493 Millions of yen (YoY +19.5%) |
| Operating profit | 671 Millions of yen (YoY +294.3%) |
| Ordinary income | 679 Millions of yen (YoY +289.4%) |
| Profit attributable to owners of the parent | 424 Millions of yen (YoY +340.9%) |
| Net income per share | ¥110.75 |
| Operating Margin | Current fiscal year 7.9 % / Previous period 2.4 % |
| Equity ratio | End of the current fiscal period 48.8 / End of previous period 41.4 |
| Total assets | 2,594 Millions of yen |
| Net assets | 1,267 Millions of yen |
| Cash flows from operating activities | 830 Millions of yen |
| Cash flows from investing activities | -7 Millions of yen |
| Cash flows from financing activities | -93 Millions of yen |
| Cash and cash equivalents at end of period | 1,631 Millions of yen |
| Full-year earnings forecast | Net Sales 10,497 Millions of yen (YoY +23.6%) / Operating profit 853 Millions of yen (YoY +27.1%) / Ordinary income 817 Millions of yen (YoY +20.4%) / Net income 523 Millions of yen (YoY +23.2%) |
| Revision to Earnings Forecast | Net Sales 10,497 Millions of yen → 10,497 Millions of yen（0.0%） / Operating profit 853 Millions of yen → 853 Millions of yen（0.0%） / Ordinary income 817 Millions of yen → 817 Millions of yen（0.0%） / Net income 523 Millions of yen → 523 Millions of yen（0.0%） |
| Annual Dividend Forecast | ¥0 per share → ¥0 per share（0.0%） |
| Segment revenue | Healthcare Sales business ¥5,911,505 thousand (YoY +14.5%), Medical Care Sales business ¥1,827,165 thousand (YoY +40.5%), Healthcare Marketing business ¥754,340 thousand (YoY +17.1%) |
| Segment profit | Healthcare Sales business ¥1,280,824 thousand (YoY +82.8%), Medical Care Sales business ¥-219,142 thousand, Healthcare Marketing business ¥-26,956 thousand |
| Depreciation and amortization | ¥5,144 thousand |
| Impairment loss | ¥0 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not applicable for the fiscal year / Extraordinary loss Loss on Disposal of Fixed Assets ¥212 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Material subsequent events | On 7 July 2021, the company split each common share into 2 shares. The number of issued shares was 1,918,500 before the share split and 3,837,000 after the split. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 3,837,000 shares |
| Treasury Shares at Period-End | — shares |
| Factors Behind Changes in Business Performance | The number of new recurring members for health foods increased substantially as a result of proactive advertising investment, the online Chinese herbal medicine shop business acquired through M&A contributed to higher revenue, and sales support using celebrities and wholesale sales for television shopping grew. Meanwhile, development and operating costs for the SOKUYAKU app, organizational development costs for the media business, and personnel expenses weighed on profit. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.For the actual results, the company cited the acquisition of recurring members for health foods through proactive advertising investment, the contribution from the online Chinese herbal medicine shop business acquired through M&A, and growth in sales support using celebrities and wholesale operations. For the forecast, it cited continued advertising investment, the launch of new products, expansion of partnerships for the online medical consultation and medication guidance service “SOKUYAKU,” and strengthening of its sales organization.